Bio Protocol Raises $6.9 Million for AI-Driven Blockchain Solutions
- Bio Protocol secured $6.9 million in funding led by Maelstrom Fund, co-founded by BitMEX’s Arthur Hayes.
- The funding will enhance AI-driven solutions for decentralized science (DeSci), streamlining scientific processes and monetizing discoveries.
- New features include on-chain fundraising and decentralized AI frameworks to support early-stage research and development.
- Bio V2 introduces innovative mechanisms like Ignition Sales for tokenized intellectual property and a rewards system called BioXP.
- The first BioAgent, Aubrai, has attracted over $900,000 in investment while generating approximately 1,000 hypotheses on the blockchain.
This funding round aims to revolutionize decentralized science through the integration of AI and blockchain technology, fostering collaboration among researchers and the crypto community. The developments in Bio V2 highlight a commitment to enhancing research capabilities and financial engagement within the ecosystem.
With $6.9 million secured, Bio Protocol is poised to significantly advance its platform’s capabilities in decentralized science, paving the way for innovative solutions in scientific exploration.
